T1	Participants 122 147	advanced cervical cancer.
T2	Participants 307 334	advanced cervical carcinoma
T3	Participants 354 511	Between May 2000 and May 2004, 31 women with FIGO stage IB2-IVA cervical cancer or with postsurgical pelvic recurrence were enrolled into this phase II study
T4	Participants 1517 1549	advanced carcinoma of the cervix
